Ivermectin modulated cerebral γ-aminobutyric acid (GABA) and reduced the number of chronic Toxoplasma gondii cysts significantly in the brains of immunocompromised mice

Disruption of GABAergic signaling could exaggerate the inflammatory reaction associated with Toxoplasma gondii infection, as well as produce neurophysiological consequences including seizures that occur within the brain tissues. The current study aimed to evaluate the efficacy of ivermectin (IVM) in...

Full description

Saved in:
Bibliographic Details
Published in:Journal of parasitic diseases 2023-09, Vol.47 (3), p.635-643
Main Authors: Fahmy, Mennat-Elrahman Ahmed, Shalaby, Maisa Ahmed, Issa, Ragaa, Badawi, Manal, Magdy, Mona, Afife, Adam Ashraf, Abdel-Aal, Amany Ahmed
Format: Article
Language:English
Subjects:
Dexamethasone
Health Promotion and Disease Prevention
Infectious Diseases
Inflammation
Ivermectin
Medicine
Medicine & Public Health
Neuromodulation
Original
Original Article
Seizures
Spiramycin
Toxoplasma
Toxoplasma gondii
Toxoplasmosis
γ-Aminobutyric acid
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Disruption of GABAergic signaling could exaggerate the inflammatory reaction associated with Toxoplasma gondii infection, as well as produce neurophysiological consequences including seizures that occur within the brain tissues. The current study aimed to evaluate the efficacy of ivermectin (IVM) in treating latent cerebral toxoplasmosis and define its role in the neuromodulation of cerebral tissue GABA expression, conducted in an immunocompromised dexamethasone-treated mouse model infected with the ME49 Toxoplasma strain. The control (non-infected non-treated) group showed a mean of 22.1 ± 0.71 for local expression of GABA. Significantly lower expression (3.78 ± 1.38) was recorded in the infected non-treated group ( p  ≤ 0.05). On the contrary, a significantly higher expression was reported in the group infected and treated with IVM than in the infected non-treated group (19.8 ± 0.8). While the infected spiramycin (SP)-treated group reported a significantly lower level than the control. Non-infected groups that received only IVM or SP recorded 22.3 ± 0.45 and 22 ± 0.89 respectively with no significant difference. IVM is shown in this work, not only to reduce the size and the number of Toxoplasma cystic lesions within the brain significantly with a reduction rate of 68.85% but to also increase the level of GABA local expression significantly in addition to improving cerebral histopathology. Thus, IVM by its ability to modulate GABA expression may improve such clinical situations, if used as a treatment either exclusively or in combination with other medications.
ISSN:0971-7196
0975-0703
DOI:10.1007/s12639-023-01608-4